But if you're not a fan of needles, the experience isn't exactly enjoyable. Enter: FluMist, the newly FDA-approved at-home ...

Earlier this week, AstraZeneca announced that the FDA is reviewing an application for its nasal spray flu vaccine FluMist, which would become the first self-administered flu vaccine available ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

While very few serious side effects have been reported, people have been known to experience mild flu shot side effects, as well as to the nasal spray flu vaccine (FluMist). Flu shots are produced ...

AIM ImmunoTech (AIM) announced that Paul Goepfert, MD, of the University of Alabama-Birmingham, has agreed to act as the Principal Investigator ...

Recently we received an alert from her transplant team that transplant patients should not take FluMist, a spray vaccine against influenza that received U.S. Food and Drug Administration approval ...

Proposed study of Ampligen as a vaccine adjuvant to increase cross-reactivity to influenza strains Paul Goepfert, MD, Director for the Alabama Vaccine Research Clinic Paul Goepfert, MD, Director for ...

This year, the Centers for Disease Control and Prevention isn’t recommending the nasal vaccine, FluMist. In the past three years, FluMist offered little protection against the flu in children ...

OCALA, Fla., Feb. 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that Paul Goepfert, MD, of the University of Alabama ...